Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03568656
Title Study to Evaluate CCS1477 in Advanced Tumours
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors CellCentric Ltd.
Indications

prostate cancer

Advanced Solid Tumor

Therapies

CCS1477

Abiraterone + CCS1477

CCS1477 + Enzalutamide

Age Groups: adult | senior
Covered Countries USA | FRA | ESP


No variant requirements are available.